Tag: osteoporosis
IOF release position paper recommending routine use of VFA-DXA in fracture...
A new position paper published in the journal Osteoporosis International by the International Osteoporosis Foundation (IOF) fracture working group, which urges for the routine...
Endo announces licensing agreement for Paladin Labs to commercialise abaloparatide in...
Endo International announced in a press release that its subsidiary Endo Ventures has entered into definitive agreements with Radius Health to register, commercialise and...
National Osteoporosis Foundation supports new evidence-based vertebral compression fracture care pathway
Medtronic has announced that the National Osteoporosis Foundation (NOF) supports the vertebral compression fracture (VCF) Care Pathway, a new evidence-based clinical care pathway...
Romosozumab receives approval in Japan for treatment of osteoporosis in patients...
The Japanese Ministry of Health, Labor and Welfare has granted a marketing authorisation for EVENITY (romosozumab; Amgen and UCB) for the treatment of osteoporosis...
Research paves way for novel therapy to treat osteoporosis
A recent study, initially published in Nature Communications, shows that anti-oxidation specific epitope (OSE) antibodies protect against osteoporosis, illuminating the potential for a novel...
More than 15% of osteoporosis patients who take drug holidays suffer...
A Loyola Medicine study has found that 15.4% of patients who take drug holidays from osteoporosis drugs called bisphosphonates experienced bone fractures. During a six-year...
Intervertebral disc narrowing greater in women than men in an elderly...
In an elderly Chinese population, intervertebral disc narrowing over a four-year period is associated with the presence of osteoporosis, and is greater in women...
Vexim launches Masterflow Plus low-energy osteoporotic fracture treatment in Germany
Vexim has launched its new Masterflow Plus treatment, targeted at low-energy vertebral compression fractures (A1-type according to Magerl and AOSpine Classifications) in osteoporotic bone,...
Safe Orthopaedics launches new products to treat traumatic injuries associated with...
Safe Orthopaedics has launched a transverse connector designed to rigidify the stabilisation of posterior spinal osteosynthesis, as well as cement injectable through the Cypress...
Romosozumab leads to significant bone mineral density gains at lumbar spine...
UCB and Amgen have announced results from the Phase 3 BRIDGE study showing that in men with osteoporosis, the investigational agent romosozumab resulted in...